AIM
MEDP icon

Ausbil Investment Management’s Medpace MEDP Stock Holding History

Ausbil Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
4,275
+221
+5% +$102K 1.05% 33
2026
Q1 		$1.98M Sell
4,054
-1,359
-25% -$696K 0.99% 30
2025
Q4 		$3.04M Buy
5,413
+2,852
+111% +$1.62M 1.73% 24
2025
Q3 		$1.39M Sell
2,561
-75
-3% -$32.7K 0.74% 34
2025
Q2 		$827K Buy
2,636
+664
+34% +$199K 0.49% 43
2025
Q1 		$601K Buy
+1,972
New +$663K 0.37% 43
2024
Q3 		– Sell
-8,724
Closed -$3.59M – 81
2024
Q2 		$3.59M Buy
8,724
+1,750
+25% +$693K 1.66% 20
2024
Q1 		$2.78M Buy
6,974
+1,504
+27% +$529K 1.39% 28
2023
Q4 		$1.68M Buy
5,470
+63
+1% +$17K 0.91% 27
2023
Q3 		$1.31M Buy
5,407
+2,375
+78% +$607K 0.81% 34
2023
Q2 		$728K Sell
3,032
-3,350
-52% -$696K 0.45% 41
2023
Q1 		$1.2M Buy
+6,382
New +$1.32M 0.84% 25

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ausbil Investment Management's MEDP Position: Q2 2026 in Review

Ausbil Investment Management increased its Medpace (MEDP) stake by 5.5% in Q2 2026, buying an estimated $102K and bringing the position to 4,275 shares worth $2.32M. The position accounts for 1.05% of the portfolio, ranked #33.

Ausbil Investment Management first reported a position in MEDP in Q1 2023 and has held it in 12 quarters since. The position peaked at $3.59M in Q2 2024. 348 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Ausbil Investment Management held 4,275 shares of Medpace worth $2.32M as of Q2 2026.
  • Ausbil Investment Management bought 221 Medpace shares in Q2 2026, an estimated $102K.
  • Medpace made up 1.05% of Ausbil Investment Management's portfolio in Q2 2026, its #33 holding.
  • Ausbil Investment Management first reported a position in Medpace in Q1 2023 and has held it in 12 quarters since.
  • Ausbil Investment Management's Medpace position peaked at $3.59M in Q2 2024.
  • 348 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Ausbil Investment Management's 13F filing for Q2 2026, filed 10 Jul 2026.